1 o, and have an effect both presplenectomy or postsplenectomy.

2 months preop: 8.6 +/- 2 units) compared with postsplenectomy (3 months postsplenectomy: 5.0 +/- 1 uni

3 its) compared with postsplenectomy (3 months postsplenectomy: 5.0 +/- 1 unit, P = 0.03).

4 ortion of adults do not respond and, despite postsplenectomy administration of PPV-23, may remain sus

5     Platelet counts were consistently higher postsplenectomy, although relative changes over time wer

6 of patients with known ITP, especially those postsplenectomy and with more refractory disease, is ind

7 ompared with preop, was observed starting on postsplenectomy day 1 (141 +/- 8 K/microL, P < 0.001 ver

8 l presentation of patients with overwhelming postsplenectomy infection (OPSI).

9 verse effect is the syndrome of overwhelming postsplenectomy infection.

10                                A significant postsplenectomy platelet rise persisted for at least 1 y

11 ality in these patients are the overwhelming postsplenectomy sepsis and development of lymphoma.

12 transplant lymphoproliferative disorder, and postsplenectomy sepsis may be avoided utilizing this tec

13 emolytic anemias is restricted by concern of postsplenectomy sepsis.

14  known risks associated with surgery and the postsplenectomy state.

15    The 203 survivors of surgery had a median postsplenectomy survival time (PSS) of 27 months (range,

16  was significantly associated with decreased postsplenectomy survival.

17 stations including anemia, splenomegaly, and postsplenectomy thrombosis.